1. Field of the Invention
The present invention relates to an interbody cage and, more particularly, to an interbody cage for spine fusion, which is capable of enhancing the growing speed and stability of bones as well as an easy 2D-to-3D conversion in structure.
2. Description of the Related Art
Recently, cases of spinal diseases have occurred often, since the numbers of office workers and elders are increasing, and spinal diseases are common in these two groups. Therefore, how to take care of patients of spinal diseases has become more and more important.
Generally, medical attention of a spinal patient after an operation is extremely important for the patient's recovery, and the patient usually has to put on a spinal brace for a long time so that the spinal brace may provide an external support for the spine of the patient and prevent the recovering spine from injury again.
Nowadays, the way to improve the patient's recovery is to implant an interbody cage in a position adjacent to a bone defect in his spine, with filler such as Calcium Phosphate, bone graft, and auto-genous graft in the interbody cage. However, the filler inside the interbody cage may easily flow away due to intrusion of soft tissues, which usually grow faster than bone tissues, in the interbody cage or circulatory system if the meshes of the interbody cage are not well designed. Thus, this implant made of the interbody cage and filler will not achieve a desirable performance.
Referring to
However, there should be a plurality of screws 96 coupling with the fixing seat 95 to firmly position the interbody cage 9 in a position adjacent to a bone defect.Futher, this conventional interbody cage 9 is suitable to be positioned between two vertebral columns only. Moreover, the complexity, difficulty in manufacture and manufacture cost of this conventional interbody cage 9 are high, since the interbody cage 9 can only be shaped by 3D laser carving and spark-discharge forming. Additionally, in a medical operation, this complex interbody cage 9 also leads to a long time period in assembly of the screws 96 and the fixing seat 95. Thus, the possibility of bacterial infection in the medical operation can be largely raised.
Furthermore, the filler loss problem due to soft tissues' intrusion and to the circulatory system may easily occur in this interbody cage 9, since the room 92 and holes 93 are not particularly designed to block the intruded soft tissues and the filler inside the room 92. Accordingly, the conventional interbody cage 9 cannot effectively enhance the growing speed of a defective bone but only serves as a support. Thus, the interbody cage 9 cannot help a lot in recovery of the bone.
Therefore, a titanium-based interbody cage for enhancing the growing speed and stability of defective bones and suitable for use in any part of the spine is needed to solve the above problems.
It is therefore the primary objective of this invention to provide an interbody cage with a simple and integral structure without any joint between any two separate members and capable of an easy 2D-to-3D conversion in structure, to lower the difficulty and cost in manufacture and to avoid undesirable deformation.
Another objective of this invention is providing an interbody cage to release stress at ends of a deformable rib to avoid an undesirable break.
Still another objective of this invention is providing an interbody cage to prevent the soft tissues from intrusion and to surely hold the filler to avoid the flowing away.
Still another objective of this invention is providing an interbody cage suitable to be used in any position of a patient with spinal disease for enhancing the growing of the bone tissues via the filler inside this interbody cage.
The invention discloses an interbody cage including a substrate. The substrate has a plurality of curve slits, with each of the curve slits having a plurality of sections.A plurality of deformable ribs is formed, with each deformable rib between any adjacent two of the curve slits and having a first end and a second end. The first and second ends of each deformable rib respectively connect with two opposite lateral bars of the substrate, and a plurality of folds is formed on the plurality of deformable ribs in places adapted to be bent.
The invention further discloses that each deformable rib has a narrow part and a wide part, with a plurality of through holes formed in the wide part and penetrating the substrate.
The invention further discloses that a plurality of end holes is formed at ends of the curve slits and penetrates the substrate.
The invention further discloses that the plurality of folds is line depressions in the substrate and parallel to the lateral bars.
The invention further discloses that a part of the folds is arranged on one side of the deformable ribs in the narrow parts forming the first ends or second ends, and the other part of the folds is arranged on another side of the deformable ribs in the wide parts forming the first ends or second ends.
The invention further discloses that a thickness of the substrate is 20-200 micrometers and that widths of the folds are in a range between 0.1-0.3 mm.
The invention further discloses that diameters of the through holes are in a range between 1-3 mm.
The invention further discloses that a biodegradable macromolecular film is formed on one side of the substrate to totally or partially cover the one side.
The invention further discloses that each section of any one of the curve slits has a first part and a second part in arc shapes. The first parts and the second parts of the sections of any one of the curve slits are arranged in a staggered manner. Curvature centers of the first parts are on one side of the curve slit, and curvature centers of the second parts are on the other side of the curve slit.
The invention further discloses that each narrow part of any one of the deformable ribs is formed between a first part and a second part of adjacent two of the curve slits defining the deformable rib, with centers of the said first and second parts being bent towards each other. Each wide part of any one of the deformable ribs is formed between a first part and a second part of adjacent two of the curve slits defining the deformable rib, with centers of the said first and second parts being bent away from each other.
The invention further discloses that the wide parts are in a circular shape and that the through holes in the wide parts are in a circular shape concentric to the circular shape of the wide parts.
The invention further discloses that the wide parts are in an eye-like shape and that the through holes in the wide parts are also in an eye-like shape.
The invention further discloses that the wide parts are in a circular shape. A part of the wide parts has the through holes in a circular shape, and the other part of the wide parts has the through holes in a bar shape. The wide parts having the circular through holes and the wide parts having the bar-shaped through holes are arranged in a staggered manner.
The invention further discloses that each first part is in an S shape and that each second part is in an arc shape.
The invention further discloses that the narrow part of one of the deformable ribs is in an S shape and that the wide part of the deformable rib is in a circle shape, with a circular through hole formed in the wide part and concentric to the circular shape of the wide part.
The invention further discloses that the wide parts are in a rhombus shape and that the through holes in the wide parts are formed in an ellipse shape.
The invention further discloses that the wide parts are in a rectangle shape and that the through holes in the wide parts are formed in an oval shape.
The present invention will become more fully understood from the detailed description given hereinafter and the accompanying drawings which are given by way of illustration only, and thus are not limitative of the present invention, and wherein:
In the various figures of the drawings, the same numerals designate the same or similar parts. Furthermore, when the term “first,” “second,” and similar terms are used hereinafter, it should be understood that these terms refer only to the structure shown in the drawings as it would appear to a person viewing the drawings, and are utilized only to facilitate describing the invention.
The substrate 1 has two lateral bars 10 on two opposite ends of the substrate 1 and a plurality of curve slits 11 extending between the two lateral bars 10. Each of the curve slits 11 has a plurality of sections 111. Routes of the curve slits 11 in the sections 111 may be the same or different to form the sections 111 with repeated or random shapes. Specifically, each slit 11 of the substrate 1 in the present example shown by
Referring to
Referring to
Moreover, a first end 123 and a second end 124 of the deformable rib 12 are defined. The first and second ends 123, 124 respectively connect with the two lateral bars 10 extending in a X direction perpendicular to the Y and Z directions. The first and second ends 123, 124 can be bent relative to the lateral bars 10 of the deformable rib 12 while the external pressure enforces the two lateral bars 10 to get close, to form the 3D cage capable of receiving the filler.
Additionally, the substrate 1 further has a plurality of folds 13 formed on at least one of the sides of the substrate 1 in places to be bent to convert the 2D flat piece into the 3D cage. In this embodiment, the plurality of folds 13 is formed on the deformable ribs 12 and adjacent to the first and second ends 123, 124. According to the user's need, the folds 13 may be formed on one side of the substrate 1 only or formed on both of the opposite sides of the substrate 1, and the folds 13 may be formed adjacent to only one of the first and second ends 123, 124 or formed adjacent to both of the first and second ends 123, 124. Each of the folds 13 is a line depression in the substrate 1, with the widths of the folds 13 in a range between 0.1-0.3 mm for the face of the deformable ribs 12 with a fold 13 to be easily bent. Thus, the deformable ribs 12 can be guided to spread out in designed directions.
Please refer to
The interbody cage according to the preferable embodiment of the invention can further have a plurality of through holes 2, with the plurality of through holes 2 penetrating the substrate 1 from one of the two opposite sides to the other one of them, to communicate these two opposite sides of the substrate 1. Particularly, the plurality of through holes 2 is formed in the wide parts 122 of the deformable rid 12 and may connect with the curve slit 11 if necessary. In the example shown in
Referring to
The interbody cage of the present invention can be made by the following method: selecting a titanium film with 50 micrometers as the substrate 1; forming the plurality of curve slits 11 and through holes 2 with the previous discussed structures by 2D laser carving; forming the fold 13 with a width of 0.2 mm by laser processing; and soaking the carved substrate 1 into 37% hydrochloric acid for 30 minutes to lower the roughness of the surfaces of the substrate 1 to a degree smaller than 1.5 micrometers.
When the interbody cage of this invention is used, the substrate 1 has to be transformed from the 2D flat piece into the integral 3D cage. Referring to
Particularly, a gap “G” is formed between two adjacent deformable ribs 12a or two adjacent deformable ribs 12b, which are on the same side of the filling room “S,” and is in a shape identical to that of a deformable rib 12b or a deformable rib 12a since the filling room “S” is formed by the oppositely bent deformable ribs 12a, 12b. Once the filler is filled into the filling room “S” in use, the filler is accessible to the bone tissues via the gap “G.” As a result, it is preferable that the width of the wide part 122 is smaller than that of the filler, with the width of the wide part 122 being 1.5-4.5 mm and more preferably being 2-4 mm, Thus the filler is firmly held inside the filling room “S” and cannot fall out of the interbody cage through the gap “G” to effectively enhance the recovery of the bone defect.
Referring to
Referring to
Referring to
In addition to the above disclosed structures, another embodiment is shown by
In sum, the interbody cage of the present invention is characterized in the following features. First, the interbody cage is easy for storage before use, since the substrate 1 is a 2D flat piece. Second, the interbody cage is convenient for use, since the deformable ribs 12 can be spread out easily by opposite external forces on the lateral bars 10 to form the 3D cage. Third, the external forces applied to the lateral bars 10 may focus on the folds 13 guiding the deformable ribs 12 to bend in designed directions in a staggered manner. Thus, the folds 13 can prevent any deformable rib 12 from an undesirable deformation. Fourth, the interbody cage is strong, since the substrate 1 is integrally formed without any joint between any two separate members. Thus, the structure of the interbody cage will not be loosened or broken from the joint. Fifth, the end holes 14 can release the stress at the first and second ends 123, 124 of the deformable ribs 12 to avoid a break of the deformable ribs 12 or the lateral bars 10. Sixth, the routes of the curve slits 11 can be designed to avoid weak points of the deformable ribs 12 and to avoid hurt to the bone. Finally, the interbody cage has a reduced weight, improved flexibility and lower interference on X-ray films, since the through holes 2 are formed in the deformable rids 12. Thereby, the present interbody cage not only can be manufactured easily, but can efficiently hold the filler as well as efficiently prevent the soft tissues from intrusion via the applied biodegradable macromolecular film 3. Accordingly, the present interbody cage can provide a sufficient strength for support as well as improve the growing of the bone tissues.
Although the invention has been described in detail with reference to its presently preferable embodiments, it will be understood by one of ordinary skill in the art that various modifications can be made without departing from the spirit and the scope of the invention, as set forth in the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
150804 | Vose | May 1874 | A |
266842 | Kitzmiller | Oct 1882 | A |
398156 | Hayes | Feb 1889 | A |
517106 | Laass | Mar 1894 | A |
603028 | Pell et al. | Apr 1898 | A |
2009496 | Johnson | Jul 1935 | A |
3389902 | Young | Jun 1968 | A |
3671030 | Marion | Jun 1972 | A |
5417602 | McGraw | May 1995 | A |
5522753 | McGraw | Jun 1996 | A |
5676702 | Ratron | Oct 1997 | A |
5749916 | Richelsoph | May 1998 | A |
5785303 | Kutschi | Jul 1998 | A |
5976187 | Richelsoph | Nov 1999 | A |
6170808 | Kutschi | Jan 2001 | B1 |
6231609 | Mehdizadeh | May 2001 | B1 |
6572653 | Simonson | Jun 2003 | B1 |
6770096 | Bolger et al. | Aug 2004 | B2 |
7867276 | Matge et al. | Jan 2011 | B2 |
8118873 | Humphreys et al. | Feb 2012 | B2 |
8262068 | Monson et al. | Sep 2012 | B1 |
8465008 | Beer et al. | Jun 2013 | B2 |
8523944 | Jimenez et al. | Sep 2013 | B2 |
8529628 | Marino et al. | Sep 2013 | B2 |
8540452 | Jimenez et al. | Sep 2013 | B2 |
20030160396 | Dean | Aug 2003 | A1 |
20050038515 | Kunzler | Feb 2005 | A1 |
20050240269 | Lambrecht et al. | Oct 2005 | A1 |
20050267471 | Biedermann et al. | Dec 2005 | A1 |
20060004455 | Leonard et al. | Jan 2006 | A1 |
20070191953 | Trieu | Aug 2007 | A1 |
20070191958 | Abdou | Aug 2007 | A1 |
20070219634 | Greenhalgh et al. | Sep 2007 | A1 |
20070293949 | Salerni et al. | Dec 2007 | A1 |
20080167686 | Trieu et al. | Jul 2008 | A1 |
20080177389 | Parrish | Jul 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20090062916 | Fox et al. | Mar 2009 | A1 |
20090138088 | Scribner et al. | May 2009 | A1 |
20100004748 | Cordaro | Jan 2010 | A1 |
20100131009 | Roebling et al. | May 2010 | A1 |
20100292799 | Hansell et al. | Nov 2010 | A1 |
20110196495 | Hunt | Aug 2011 | A1 |
20120025576 | Stern et al. | Feb 2012 | A1 |
20120203346 | Kraus | Aug 2012 | A1 |
20120265306 | Trieu | Oct 2012 | A1 |
20120318574 | Beer et al. | Dec 2012 | A1 |
20130023990 | Zipnick et al. | Jan 2013 | A1 |
20130053963 | Davenport | Feb 2013 | A1 |
20130166030 | Biedermann et al. | Jun 2013 | A1 |
Number | Date | Country |
---|---|---|
M333884 | Jun 2008 | TW |
Number | Date | Country | |
---|---|---|---|
20130173000 A1 | Jul 2013 | US |